XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2022   541,364,000      
Balance at the beginning of the period at Dec. 31, 2022 $ 1,472,956 $ 53 $ 2,082,373 $ (7,237) $ (602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   803,000      
Issuance of common stock upon exercise of options 1,051   1,051    
Issuance of common stock net settlement of restricted stock units (in shares)   1,470,000      
Issuance of common stock upon net settlement of restricted stock units (3,746)   (3,746)    
Vesting of common stock warrants 2,102   2,102    
Share-based compensation 33,906   33,906    
Executive chairman long-term performance award 13,121   13,121    
Repurchase and retirement of common stock, including excise tax (in shares)   (3,206,000)      
Repurchase and retirement of common stock, including excise tax (20,993)   (20,993)    
Change in accumulated other comprehensive income (loss) 4,054     4,054  
Net income (loss) (68,801)       (68,801)
Balance at the end of the period (in shares) at Mar. 31, 2023   540,431,000      
Balance at the end of the period at Mar. 31, 2023 1,433,650 $ 53 2,107,814 (3,183) (671,034)
Balance at the beginning of the period (in shares) at Dec. 31, 2022   541,364,000      
Balance at the beginning of the period at Dec. 31, 2022 1,472,956 $ 53 2,082,373 (7,237) (602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Executive chairman long-term performance award 26,388        
Change in accumulated other comprehensive income (loss) 5,761        
Net income (loss) (127,598)        
Balance at the end of the period (in shares) at Jun. 30, 2023   534,216,000      
Balance at the end of the period at Jun. 30, 2023 1,372,615 $ 52 2,103,870 (1,476) (729,831)
Balance at the beginning of the period (in shares) at Mar. 31, 2023   540,431,000      
Balance at the beginning of the period at Mar. 31, 2023 1,433,650 $ 53 2,107,814 (3,183) (671,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   828,000      
Issuance of common stock upon exercise of options 1,310   1,310    
Issuance of common stock under employee stock purchase plan (in shares)   446,000      
Issuance of common stock under employee stock purchase plan 1,775   1,775    
Issuance of common stock net settlement of restricted stock units (in shares)   2,679,000      
Issuance of common stock upon net settlement of restricted stock units (6,324)   (6,324)    
Vesting of common stock warrants 2,372   2,372    
Share-based compensation 32,152   32,152    
Executive chairman long-term performance award 13,267   13,267    
Repurchase and retirement of common stock, including excise tax (in shares)   (10,168,000)      
Repurchase and retirement of common stock, including excise tax (48,497) $ (1) (48,496)    
Change in accumulated other comprehensive income (loss) 1,707     1,707  
Net income (loss) (58,797)       (58,797)
Balance at the end of the period (in shares) at Jun. 30, 2023   534,216,000      
Balance at the end of the period at Jun. 30, 2023 1,372,615 $ 52 2,103,870 (1,476) (729,831)
Balance at the beginning of the period (in shares) at Dec. 31, 2023   520,343,000      
Balance at the beginning of the period at Dec. 31, 2023 1,243,395 $ 52 2,067,776 762 (825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   98,000      
Issuance of common stock upon exercise of options 49   49    
Issuance of common stock net settlement of restricted stock units (in shares)   2,806,000      
Issuance of common stock upon net settlement of restricted stock units (10,917)   (10,917)    
Vesting of common stock warrants 2,100   2,100    
Share-based compensation 33,393   33,393    
Executive chairman long-term performance award 13,121   13,121    
Repurchase and retirement of common stock, including excise tax (in shares)   (5,238,000)      
Repurchase and retirement of common stock, including excise tax (32,830)   (32,830)    
Change in accumulated other comprehensive income (loss) (1,586)     (1,586)  
Net income (loss) (36,060)       (36,060)
Balance at the end of the period (in shares) at Mar. 31, 2024   518,009,000      
Balance at the end of the period at Mar. 31, 2024 1,210,665 $ 52 2,072,692 (824) (861,255)
Balance at the beginning of the period (in shares) at Dec. 31, 2023   520,343,000      
Balance at the beginning of the period at Dec. 31, 2023 1,243,395 $ 52 2,067,776 762 (825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Executive chairman long-term performance award (144,617)        
Change in accumulated other comprehensive income (loss) (2,035)        
Net income (loss) 83,048        
Balance at the end of the period (in shares) at Jun. 30, 2024   510,748,000      
Balance at the end of the period at Jun. 30, 2024 1,142,375 $ 51 1,885,744 (1,273) (742,147)
Balance at the beginning of the period (in shares) at Mar. 31, 2024   518,009,000      
Balance at the beginning of the period at Mar. 31, 2024 1,210,665 $ 52 2,072,692 (824) (861,255)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of options (in shares)   33,000      
Issuance of common stock upon exercise of options 59   59    
Issuance of common stock under employee stock purchase plan (in shares)   327,000      
Issuance of common stock under employee stock purchase plan 1,629   1,629    
Issuance of common stock net settlement of restricted stock units (in shares)   3,338,000      
Issuance of common stock upon net settlement of restricted stock units (9,370)   (9,370)    
Share-based compensation 38,209   38,209    
Executive chairman long-term performance award (157,738)   (157,738)    
Repurchase and retirement of common stock, including excise tax (in shares)   (10,959,000)      
Repurchase and retirement of common stock, including excise tax (59,738) $ (1) (59,737)    
Change in accumulated other comprehensive income (loss) (449)     (449)  
Net income (loss) 119,108       119,108
Balance at the end of the period (in shares) at Jun. 30, 2024   510,748,000      
Balance at the end of the period at Jun. 30, 2024 $ 1,142,375 $ 51 $ 1,885,744 $ (1,273) $ (742,147)